Frontiers | Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases
Chronic kidney disease: scrutiny of HIF PHIs may derail approvals
HIF-PHD inhibitors in renal anemia | Update on phase 3 clinical trials
An Overview of Safety and Efficacy Between Hypoxia-Inducible Factor-Prolyl-Hydroxylase Inhibitors and Erythropoietin-Stimulating
HIF Stabilizers Get in Sync: Are ESAs Bye Bye Bye? in: Kidney News Volume 13 Issue 3 (2021)
ISN ACT Webinar: Hypoxia inducible factor-prolyl hydroxylase inhibitors (HIF -PHIs) - International Society of Nephrology
The effect of HIF on metabolism and immunity | Nature Reviews Nephrology
JCI - Von Hippel–Lindau disease: insights into oxygen sensing, protein degradation, and cancer
Integrity CE SoMe CME on X: "5/ Emerging therapeutic strategy for CKD-related anemia: HIF-PHIs ✓ Stabilize HIFs ⬆️ Erythropoiesis via ⬆️ renal & hepatic EPO production ⬇️ Hepcidin levels & modulate iron
Anemia in Patients with CVD and CKD: Current Management and Potential Role of HIF-PHIs | CCO
JCM | Free Full-Text | Current Status of Renal Anemia Pharmacotherapy—What Can We Offer Today
Roxadustat for the Management of Patients With CKD-Related Anemia | Docwire News
![MK8617 inhibits M1 macrophage polarization and inflammation via the HIF-1α/GYS1/UDPG/P2Y14 pathway [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2023/15591/1/fig-6-full.png "MK8617 inhibits M1 macrophage polarization and inflammation via the HIF-1α/GYS1/UDPG/P2Y14 pathway [PeerJ]")
MK8617 inhibits M1 macrophage polarization and inflammation via the HIF-1α/GYS1/UDPG/P2Y14 pathway [PeerJ]
Overview of hypoxia-inducible factor (HIF) regulation of... | Download Scientific Diagram
Edgar V. Lerma 🇵🇭 on X: "Elegant discussion of HIF pathway by Dr Wish: Inhibition of PHD via HIF-PHIs creates a "pseudo-hypoxic" environment that prevents the degradation of HIF-α ⬆️EPO synthesis ⬆️Fe
Anemia of chronic kidney disease: Will new agents deliver on their promise? | Cleveland Clinic Journal of Medicine
Mechanism of action of HIF stabilizers. Under normal conditions, the... | Download Scientific Diagram
Neuroprotection effect of HIF-PHIs. Preischemic treatment with... | Download Scientific Diagram
Novel roles of HIF-PHIs in chronic kidney disease: the link between iron metabolism, kidney function, and FGF23 - ScienceDirect
Cardiac and Kidney Adverse Effects of HIF Prolyl-Hydroxylase Inhibitors for Anemia in Patients With CKD Not Receiving Dialysis: A Systematic Review and Meta-analysis - ScienceDirect
What HIF? Leaving More Questions Than Answers – AJKD Blog
Frontiers | Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases
Biomedicines | Free Full-Text | HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
Frontiers | WT1: The Hinge Between Anemia Correction and Cancer Development in Chronic Kidney Disease
